DI
SLNO

Deeter Investments’s Soleno Therapeutics SLNO Stock Holding History

Deeter Investments’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.34M Buy
+129,500
New +$5.08M 0.49% 44

Other funds holding SLNO

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.19B AUM 14.29% 1-Year Est. Return

Deeter Investments's SLNO Position: Q1 2026 in Review

Deeter Investments opened a new position in Soleno Therapeutics (SLNO) in Q1 2026: 129,500 shares worth $4.34M. The stake represents 0.49% of the portfolio and ranks #44 among its holdings.

227 funds tracked by Wall St. Rank hold SLNO as of Q1 2026.

  • Deeter Investments held 129,500 shares of Soleno Therapeutics worth $4.34M as of Q1 2026.
  • Soleno Therapeutics was a new Deeter Investments position in Q1 2026.
  • Soleno Therapeutics made up 0.49% of Deeter Investments's portfolio in Q1 2026, its #44 holding.
  • 227 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2026.

Based on Deeter Investments's 13F filing for Q1 2026, filed 22 Sep 2026.